Obata et al. developed a new platinum-191-labeled compound based on pyrrole-imidazole polyamide (PIP), which can specifically bind to DNA containing the MYCN gene target sequence and significantly inhibit the viability of the neuroblastoma cell line Kelly of with high MYCN expression. This evidence concerns the gene MYCN and neuroblastoma.